because the levels achieved in serum with oral ganciclovir approximated those required to inhibit cytomegalovirus in vitro , a trial of oral maintenance therapy in immunocompromised patients with severe cytomegalovirus infections seems warranted .
C0017066
ganciclovir
C0010823
cytomegalovirus infections